Skip to content
Preprint · OA via OpenAlex

Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy

Agnese Fiori, Vincenzo Terlizzi, Heiner Kremer, Julian E. Gebauer, Hans‐Peter Hammes, Martin C. Harmsen, Karen Bieback

Immunobiology · 2018 · ▲ 69 citations

Abstract

This review in Immunobiology 2018 examines the potential use of mesenchymal stromal and stem cells as a therapeutic approach for diabetic retinopathy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.imbio.2018.01.001
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Fiori, A., Terlizzi, V., Kremer, H., Gebauer, J.E., Hammes, H., Harmsen, M.C., &amp; Bieback, K. (2018). Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy. <em>Immunobiology</em>. https://doi.org/10.1016/j.imbio.2018.01.001
Vancouver
Fiori A, Terlizzi V, Kremer H, Gebauer JE, Hammes H, Harmsen MC, et al. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy. Immunobiology. 2018. doi:10.1016/j.imbio.2018.01.001.
BibTeX
@unpublished{agnese2018Mesenc, title = {Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy}, author = {Agnese Fiori and Vincenzo Terlizzi and Heiner Kremer and Julian E. Gebauer and Hans‐Peter Hammes and Martin C. Harmsen and Karen Bieback}, journal = {Immunobiology}, year = {2018}, doi = {10.1016/j.imbio.2018.01.001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings